Sponsored by

State's fastest-growing biotech leases two former Cubist buildings, expands HQ by 20%

The lease puts the Irish drugmaker's total square footage in Lexington well over the 1 million mark.

Ariad replaces longtime CFO, hires second C-level officer this year

The appointment comes after the Jan. 1 appointment of Paris Panayiotopoulos, 41, as the second CEO in the company’s 24-year history.

Biogen says it will appeal revocation of European patent for top-selling drug

In an email to the Business Journal Friday, a Biogen spokesman said the company is “disappointed” in the decision and plans to appeal.

Medical community mobilizing against legalized marijuana in Massachusetts

The state's medical community is voicing strong opposition to recreational use of marijuana, formally speaking out for the first time this week against a statewide ballot campaign to legalize the drug.

Allen Institute for Brain Science receives $18.7M to help reconstruct the complex wiring of the brain

Medicare's prescription drug proposal raises some hackles